FluroTech Ltd

OTCQB:FLURF USA Medical Devices
Market Cap
$34.81K
Market Cap Rank
#43066 Global
#13833 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$0.63
About

FluroTech Ltd. focuses on the commercialization of fluorescence spectroscopy technology to test for COVID-19. FluroTech Ltd. is based in Calgary, Canada.

FluroTech Ltd (FLURF) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2024: 3.536x

Based on the latest financial reports, FluroTech Ltd (FLURF) has a cash flow conversion efficiency ratio of 3.536x as of September 2024.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-422.89K) by net assets ($-119.58K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

FluroTech Ltd - Cash Flow Conversion Efficiency Trend (2016–2023)

This chart illustrates how FluroTech Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

FluroTech Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of FluroTech Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for FluroTech Ltd (2016–2023)

The table below shows the annual cash flow conversion efficiency of FluroTech Ltd from 2016 to 2023.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2023-12-31 $-180.35K $-149.90K 0.831x -63.39%
2022-12-31 $-86.88K $-197.21K 2.270x +173.50%
2021-12-31 $779.31K $-2.41 Million -3.089x +27.13%
2020-12-31 $468.24K $-1.98 Million -4.239x -252.00%
2019-12-31 $3.04 Million $-3.66 Million -1.204x -55.13%
2018-12-31 $5.70 Million $-4.42 Million -0.776x +89.06%
2017-12-31 $129.01K $-915.66K -7.097x -3522.37%
2016-12-31 $173.12K $-33.92K -0.196x --